Donate today and your gift will be tripled by our friends at Post-it® Brand. Help us make more tomorrows possible for patients everywhere.
Help us help you. Many of the patients and families whose lives we've touched choose to say "thank you" by contributing to our mission. Learn more.
Create a personal fundraising page with ourHope to tell your story and help raise funds to benefit City of Hope's research.
A gift left to City of Hope in your will or trust is an opportunity to communicate your values and your dreams for the future. Learn about easy ways to create your legacy.
City of Hope's community of donors, fundraisers and supporters are dedicated, passionate and span the globe. Check out donor stories, read our blog, view our donor recognition gallery and connect in social media.
A team from City of Hope is working on a vaccine for congenital cytomegalovirus (CMV), symptoms of which can range from hearing and vision loss to intellectual disability to small head size to frequent seizures. More than half of adults over the age of 40 are infected with the virus.
Many people struggle with both diabetes and cancer at the same time — none of this is random or coincidental. Rather, it's clear that, from biology to risk factors to treatment options, cancer and diabetes are intimately related in many ways.
A cure for Type 1 diabetes (T1D) in six years is the new goal of City of Hope’s Diabetes and Metabolism Research Institute. With more than $50 million in private funding, the institute will be able to lead an innovative research effort that seeks to find a cure for T1D.
Diabetes affects over 422 million people worldwide according to the World Health Organization, but no two patients are alike. So in 2017 and beyond, treatments will increasingly make use of precision medicine to personalize treatment options. At City of Hope, researchers are combining the forces of a transformative gift with new resources to speed these treatments to patients.
At City of Hope, scientists are using a transformative gift to speed type 1 diabetes therapies to patients.